The FDA released draft guidance outlining the information sponsors should include on the Indications and Usage section of drug and biologics labeling.
Source: Drug Industry Daily
The FDA released draft guidance outlining the information sponsors should include on the Indications and Usage section of drug and biologics labeling.
Source: Drug Industry Daily